Company intelligence / Profile preview

Acoustic Wave Cell Therapy

Van Nuys, California, USAawct.us ↗

Ownership: Private
Employees: ~25
Development stage: Preclinical

Overview

AWCT’s platform is based on over 20 years of research at UCSF, supported by NIH and DOD grants. The company holds exclusive rights to a portfolio of 21 issued US patents and 9 foreign applications. Over 65 peer-reviewed articles support the underlying science. Clinical results have not been published or summarized publicly as of June 2025; the device remains investigational.

Therapeutic areas: Women's HealthMen's Health
Modalities: DeviceNon-pharmacological therapyRegenerative cellular therapy (via acoustic shockwave technology)
Industry: Therapeutic Medical Devices

Partnerships

Exclusive license with University of California San Francisco for core technology IP.Utilizes patent portfolio from Tissue Regeneration Technologies.

Beyond the preview

Go deeper on Acoustic Wave Cell Therapy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acoustic Wave Cell Therapy.

Explore the full profile